Option chain shows key data for Kerry Group's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Kerry Group.

Kerry Group (OTC:KRYAY) Stock, Option Chain

Kerry Group

KERRY GROUP PLC

Kerry Group is one of the largest taste and ingredient technology companies in the world servicing the food, beverage, and pharmaceutical sectors. The company has more than 200 locations that supply clients in more than 50 countries. Its taste and nutrition unit gets around 70% of its revenue from developed countries and 30% from the developing world, servicing a wide range of end-use sectors, such as meat, meals, snacks, dairy, drinks, and pharmaceuticals. Kerry has expanded through a combination of organic development and dozens of tuck-in acquisitions.

ASHTY

ENGGY

ESLOY

KRYAY

LRLCY

Nestle Sponsored representing Registered Shares Series B

NSRGY

RHHBY

WTKWY

CLPBY

In general, Dividend Aristocrats are the foundation for the portfolios of most serious dividend growth investors. European Dividend aristocrats are typically blue chip stocks that have proven to reward shareholders with rising dividends over a long period.

15 European Dividend Aristocrats To Diversify Your Portfolio

News

Intraday Update

Markets

Movers

Trading Ideas

ABBRF

ACGL

ADBE

ADSK

ADVM

AEHR

AEMMY

AFGC

AGNC

AMRC

AMWD

AMXEF

ANSS

ARCAY

ARCVF

ARDC

ARNC

ATVI

AVXL

AZMTF

AZRE

BABYF

BLDP

BLDR

BRSGF

BWXT

CACI

CALA

CCYC

CDNS

CELH

CEVA

CGEN

CHDN

CHTR

CLGX

CNNE

COST

CRMT

CROL

CSLLY

CTAS

CVNA

CWEN

CWEN-A

DBOEY

DGIF

DNNGY

DOCU

DOGEF

DOOO

DOOR

Stocks That Hit 52-Week Highs On Wednesday

AACTF

ADUS

AMXVF

APPF

APPN

APTO

ARCE

ASNB

ATGFF

ATRC

BCYC

BILI

BOWFF

BURL

BXMT

CDLX

CDPYF

CFBK

CFFA

CLHRF

CLPBF

CMCLF

CMLEF

CMXHF

CPRT

CPWHF

CTXXF

CWST

DIMC

DLT RESOLUTION INC by DLT Resolution Inc.

DLTI

DRTGF

EDPFY

Stocks That Hit 52-Week Highs On Tuesday

Kerry Group PLC

Long Ideas

Global

General

&nbsp;
<h2>Upgrades</h2>
<ul>
<li>Barrington Research upgraded the previous rating for Dentsply Sirona Inc (NASDAQ:<a class="ticker" href="/stock/XRAY#NASDAQ">XRAY</a>) from Market Perform to Outperform. Dentsply Sirona earned $0.87 in the fourth quarter, compared to $0.73 in the year-ago quarter. The stock has a 52-week-high of $60.78 and a 52-week-low of $31.57. At the end of the last trading period, Dentsply Sirona closed at $59.71.</li>
<li>BTIG upgraded the previous rating for TrueCar Inc (NASDAQ:<a class="ticker" href="/stock/TRUE#NASDAQ">TRUE</a>) from Neutral to Buy. For the fourth quarter, TrueCar had an EPS of $0.01, compared to year-ago quarter EPS of $0.01. At the moment, the stock has a 52-week-high of $6.47 and a 52-week-low of $1.98. TrueCar closed at $5.18 at the end of the last trading period.</li>
<li>For Zoom Video Communications Inc (NASDAQ:<a class="ticker" href="/stock/ZM#NASDAQ">ZM</a>), Piper Sandler upgraded the previous rating of Neutral to Overweight. For the fourth quarter, Zoom Video Communications had an EPS of $1.22, compared to year-ago quarter EPS of $0.15. At the moment, the stock has a 52-week-high of $588.84 and a 52-week-low of $97.37. Zoom Video Communications closed at $409.66 at the end of the last trading period.</li>
<li>CIBC upgraded the previous rating for Bank of Nova Scotia (NYSE:<a class="ticker" href="/stock/BNS#NYSE">BNS</a>) from Neutral to Outperformer. In the first quarter, Bank of Nova Scotia showed an EPS of $1.44, compared to $1.41 from the year-ago quarter. The stock has a 52-week-high of $61.35 and a 52-week-low of $31.94. At the end of the last trading period, Bank of Nova Scotia closed at $59.74.</li>
<li>According to BMO Capital, the prior rating for Extra Space Storage Inc (NYSE:<a class="ticker" href="/stock/EXR#NYSE">EXR</a>) was changed from Market Perform to Outperform. In the fourth quarter, Extra Space Storage showed an EPS of $1.48, compared to $1.27 from the year-ago quarter. The stock has a 52-week-high of $131.59 and a 52-week-low of $72.70. At the end of the last trading period, Extra Space Storage closed at $123.67.</li>
<li>Exane BNP Paribas upgraded the previous rating for Tenaris SA (NYSE:<a class="ticker" href="/stock/TS#NYSE">TS</a>) from Underperform to Neutral. Tenaris earned $0.18 in the fourth quarter, compared to $0.26 in the year-ago quarter. The current stock performance of Tenaris shows a 52-week-high of $21.97 and a 52-week-low of $8.86. Moreover, at the end of the last trading period, the closing price was at $21.55.</li>
<li>For Satsuma Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="/stock/STSA#NASDAQ">STSA</a>), Credit Suisse upgraded the previous rating of Underperform to Neutral. Satsuma Pharmaceuticals earned $0.69 in the third quarter, compared to $2.26 in the year-ago quarter. The stock has a 52-week-high of $36.10 and a 52-week-low of $3.50. At the end of the last trading period, Satsuma Pharmaceuticals closed at $6.51.</li>
<li>For Repay Holdings Corp (NASDAQ:<a class="ticker" href="/stock/RPAY#NASDAQ">RPAY</a>), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. Repay Holdings earned $0.17 in the fourth quarter, compared to $0.20 in the year-ago quarter. The current stock performance of Repay Holdings shows a 52-week-high of $28.42 and a 52-week-low of $10.69. Moreover, at the end of the last trading period, the closing price was at $22.63.</li>
<li>According to KeyBanc, the prior rating for Akamai Technologies Inc (NASDAQ:<a class="ticker" href="/stock/AKAM#NASDAQ">AKAM</a>) was changed from Sector Weight to Overweight. In the fourth quarter, Akamai Technologies showed an EPS of $1.33, compared to $1.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of $124.91 and a 52-week-low of $75.18. Akamai Technologies closed at $95.94 at the end of the last trading period.</li>
</ul>
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings upgrades.</a>
&nbsp;
<h2>Downgrades</h2>
<ul>
<li>According to Wedbush, the prior rating for Skyline Champion Corp (NYSE:<a class="ticker" href="/stock/SKY#NYSE">SKY</a>) was changed from Outperform to Neutral. In the third quarter, Skyline Champion showed an EPS of $0.38, compared to $0.32 from the year-ago quarter. The stock has a 52-week-high of $47.57 and a 52-week-low of $10.82. At the end of the last trading period, Skyline Champion closed at $46.86.</li>
<li>For ADT Inc (NYSE:<a class="ticker" href="/stock/ADT#NYSE">ADT</a>), Barclays downgraded the previous rating of Equal-Weight to Underweight. ADT earned $0.12 in the fourth quarter, compared to $0.03 in the year-ago quarter. The current stock performance of ADT shows a 52-week-high of $17.21 and a 52-week-low of $3.40. Moreover, at the end of the last trading period, the closing price was at $7.73.</li>
<li>For Inseego Corp (NASDAQ:<a class="ticker" href="/stock/INSG#NASDAQ">INSG</a>), Stifel downgraded the previous rating of Buy to Hold. In the fourth quarter, Inseego showed an EPS of $0.07, compared to $0.10 from the year-ago quarter. The stock has a 52-week-high of $21.93 and a 52-week-low of $3.91. At the end of the last trading period, Inseego closed at $15.03.</li>
<li>According to Raymond James, the prior rating for Switch Inc (NYSE:<a class="ticker" href="/stock/SWCH#NYSE">SWCH</a>) was changed from Strong Buy to Outperform. In the fourth quarter, Switch showed an EPS of $0.06, compared to $0.04 from the year-ago quarter. The current stock performance of Switch shows a 52-week-high of $19.99 and a 52-week-low of $10.30. Moreover, at the end of the last trading period, the closing price was at $17.69.</li>
<li>According to Needham, the prior rating for Applied Optoelectronics Inc (NASDAQ:<a class="ticker" href="/stock/AAOI#NASDAQ">AAOI</a>) was changed from Buy to Hold. Applied Optoelectronics earned $0.20 in the fourth quarter, compared to $0.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of $17.57 and a 52-week-low of $5.00. Applied Optoelectronics closed at $9.02 at the end of the last trading period.</li>
<li>For Athenex Inc (NASDAQ:<a class="ticker" href="/stock/ATNX#NASDAQ">ATNX</a>), Truist Securities downgraded the previous rating of Buy to Hold. In the fourth quarter, Athenex showed an EPS of $0.53, compared to $0.28 from the year-ago quarter. At the moment, the stock has a 52-week-high of $15.24 and a 52-week-low of $5.24. Athenex closed at $5.46 at the end of the last trading period.</li>
<li>According to Jefferies, the prior rating for FibroGen Inc (NASDAQ:<a class="ticker" href="/stock/FGEN#NASDAQ">FGEN</a>) was changed from Buy to Hold. For the fourth quarter, FibroGen had an EPS of $0.64, compared to year-ago quarter EPS of $1.12. At the moment, the stock has a 52-week-high of $57.21 and a 52-week-low of $22.65. FibroGen closed at $50.53 at the end of the last trading period.</li>
<li>For Viatris Inc (NASDAQ:<a class="ticker" href="/stock/VTRS#NASDAQ">VTRS</a>), JP Morgan downgraded the previous rating of Overweight to Neutral. The current stock performance of Viatris shows a 52-week-high of $18.86 and a 52-week-low of $14.56. Moreover, at the end of the last trading period, the closing price was at $14.72.</li>
<li>JP Morgan downgraded the previous rating for Athenex Inc (NASDAQ:<a class="ticker" href="/stock/ATNX#NASDAQ">ATNX</a>) from Overweight to Neutral. For the fourth quarter, Athenex had an EPS of $0.53, compared to year-ago quarter EPS of $0.28. The current stock performance of Athenex shows a 52-week-high of $15.24 and a 52-week-low of $5.24. Moreover, at the end of the last trading period, the closing price was at $5.46.</li>
</ul>
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings downgrades.</a>
<h2>Initiations</h2>
<ul>
<li>For Lucira Health Inc (NASDAQ:<a class="ticker" href="/stock/LHDX#NASDAQ">LHDX</a>), William Blair initiated coverage, by setting the current rating at Outperform. The stock has a 52-week-high of $37.98 and a 52-week-low of $18.27. At the end of the last trading period, Lucira Health closed at $19.39.</li>
<li>Stifel initiated coverage on Angion Biomedica Corp (NASDAQ:<a class="ticker" href="/stock/ANGN#NASDAQ">ANGN</a>) with a Buy rating. The price target for Angion Biomedica is set to $40.00. The stock has a 52-week-high of $26.30 and a 52-week-low of $16.00. At the end of the last trading period, Angion Biomedica closed at $19.92.</li>
<li>Benchmark initiated coverage on Clene Inc (NASDAQ:<a class="ticker" href="/stock/CLNN#NASDAQ">CLNN</a>) with a Buy rating. The price target for Clene is set to $25.00. The stock has a 52-week-high of $16.50 and a 52-week-low of $6.23. At the end of the last trading period, Clene closed at $13.58.</li>
<li>Guggenheim initiated coverage on Bolt Biotherapeutics Inc (NASDAQ:<a class="ticker" href="/stock/BOLT#NASDAQ">BOLT</a>) with a Buy rating. The price target for Bolt Biotherapeutics is set to $42.00. The stock has a 52-week-high of $35.88 and a 52-week-low of $22.63. At the end of the last trading period, Bolt Biotherapeutics closed at $30.00.</li>
<li>Morgan Stanley initiated coverage on MP Materials Corp (NYSE:<a class="ticker" href="/stock/MP#NYSE">MP</a>) with an Overweight rating. The price target for MP Materials is set to $57.00. At the moment, the stock has a 52-week-high of $49.43 and a 52-week-low of $15.45. MP Materials closed at $46.37 at the end of the last trading period.</li>
<li>With an Overweight rating, Morgan Stanley initiated coverage on Bolt Biotherapeutics Inc (NASDAQ:<a class="ticker" href="/stock/BOLT#NASDAQ">BOLT</a>). The price target seems to have been set at $45.00 for Bolt Biotherapeutics. The stock has a 52-week-high of $35.88 and a 52-week-low of $22.63. At the end of the last trading period, Bolt Biotherapeutics closed at $30.00.</li>
<li>With an Outperform rating, SVB Leerink initiated coverage on Pharvaris NV (NASDAQ:<a class="ticker" href="/stock/PHVS#NASDAQ">PHVS</a>). The price target seems to have been set at $50.00 for Pharvaris. The current stock performance of Pharvaris shows a 52-week-high of $42.86 and a 52-week-low of $23.06. Moreover, at the end of the last trading period, the closing price was at $39.23.</li>
<li>With a Neutral rating, Goldman Sachs initiated coverage on Immunocore Holdings PLC (NASDAQ:<a class="ticker" href="/stock/IMCR#NASDAQ">IMCR</a>). The price target seems to have been set at $40.00 for Immunocore Holdings. The current stock performance of Immunocore Holdings shows a 52-week-high of $61.99 and a 52-week-low of $39.02. Moreover, at the end of the last trading period, the closing price was at $49.05.</li>
<li>With an Overweight rating, Piper Sandler initiated coverage on AVITA Medical Inc (NASDAQ:<a class="ticker" href="/stock/RCEL#NASDAQ">RCEL</a>). The price target seems to have been set at $27.00 for AVITA Medical. AVITA Medical earned $0.26 in the second quarter. The current stock performance of AVITA Medical shows a 52-week-high of $30.78 and a 52-week-low of $4.00. Moreover, at the end of the last trading period, the closing price was at $21.49.</li>
</ul>
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings initiations.</a>

Upgrades

Downgrades

Initiation

Analyst Ratings

AAOI

AKAM

ANGN

ATNX

BHCCF

BOLT

CDMGF

CGJTF

CLNN

CRPLF

FGEN

HOYFF

IMCR

INSG

KBCSY

LHDX

PHVS

RCEL

REMYY

RPAY

STSA

STWRY

SWCH

THNPF

TMSNY

TRUE

VTRS

XRAY

Benzinga's Top Ratings Upgrades, Downgrades For March 2, 2021

JP Morgan analyst Celine Pannuti upgrades Kerry Group (OTC:<a class="ticker" href="/stock/KRYAY#OTC">KRYAY</a>) from Neutral to Overweight.

JP Morgan Upgrades Kerry Group to Overweight

It is mid-March and that means two things: March Madness and St. Patrick&#39;s Day. The latter is a reason to dress up in green, drink beer and eat some bangers and mash.
<h3>
	Ireland: Regaining</h3>

	There wasn&#39;t much celebrating in Ireland a few years ago as the country was dealing with major issues related to the financial crisis. But today, the member of the PIIGS group is now sporting one of the best economies in Europe. Over the next few years, economists expect Ireland&#39;s GDP to grow by 3 to 4 percent, well above the less than 2 percent expected for Europe as a whole.

	<bzrelatedlink>Related Link: <a href="http://www.benzinga.com/pressreleases/15/03/p5327061/st-patricks-day-promotion-15-calling-bonus-on-keepcalling-com">St. Patrick&#39;s Day Promotion: 15% Calling Bonus On KeepCalling.com</a></bzrelatedlink>
<h3>
	iShares MSCI Ireland Capped ETF</h3>

	Americans looking to invest in the continued rebound in the Emerald Isle can turn to the iShares MSCI Irld Cp Invstb Mrkt Indx Fd (NYSE: <a class="ticker" href="/stock/eirl#NYSE">EIRL</a>). The ETF is made up of 25 Irish stocks that are fairly diverse throughout the materials, consumer staples, industrials and financial sectors.

	While the ETF may be diverse as far as sectors, it is heavily weighted in the top holdings, with CRH PLC (ADR) (NYSE: <a class="ticker" href="/stock/crh#NYSE">CRH</a>) making up 21 percent of the portfolio.
<h3>
	A Closer Look</h3>

	The building materials company has been on a roller coaster ride lately, and EIRL has followed a similar pattern. The other top holdings include Kerry Group PLC (ADR) (OTC: <a class="ticker" href="/stock/kryay#OTC">KRYAY</a>) and Bank of Ireland (ADR) (OTC: <a class="ticker" href="/stock/ireby#OTC">IREBY</a>) making up 22 percent combined.

	After a huge rally from 2012 to early 2014, the ETF took a breather and pulled back through most of 2014, as it lagged many of its peers. Over the last few months, the ETF has been forming a base and broke the downtrend line in early 2015.

	From a pure technical view, it appears EIRL is ready to start a new longer-term uptrend. And if not, at least go enjoy a pint of Guinness.
Image credit: <a href="http://www.flickr.com/photos/jdhancock/7175331883">JD Hancock</a>, Flickr

Emerging Market ETFs

ETFs

iShares MSCI Ireland Capped Investable Market Index Fund

EIRL

IREBY

Here's An ETF To Look At For Your St. Patrick's Day

A recent report by Bank of America focused on investment themes for a changing world. One of the areas that the report identified as a source of change is the growing obesity epidemic.

	This problem is not just an American problem, and Bank of America analysts use the term &ldquo;globesity&rdquo; to refer to the worldwide obesity issue. The number of overweight or obese people in the word has tripled since 1980, and nearly a third of the world&rsquo;s population is now overweight. Analysts predict that nearly half of the world will be overweight or obese by 2030.

	Obesity-related conditions account for more than 3.4 million adult deaths per year. The report states that lifetime health-care costs for obese people are about 40 percent higher than for normal-weight patients. The cost of globesity is estimated at 2.8 percent of global GDP, and the recent spike in childhood obesity and obesity in emerging market countries is a bad sign for the future.

	Analysts see four potential ways to invest in the fight against globesity:
<ol>
<li>
		Pharmaceuticals, healthcare, and medical technology</li>
<li>
		Health food and nutrition</li>
<li>
		Weight loss and diet programs</li>
<li>
		Fitness apparel and equipment</li>
</ol>

	The stocks that Bank of America recommends as a means to capitalize on the opportunities that will be created by the globesity problem include the following:
<ul>
<li>
		Repros Therepeutics Inc (NASDAQ: <a class="ticker" href="/stock/rprx#NASDAQ">RPRX</a>), developer of low testosterone treatment drug Androxal</li>
<li>
		Orexigen Therapeutics, Inc.&nbsp;(NASDAQ: <a class="ticker" href="/stock/orex#NASDAQ">OREX</a>), developer of anti-obesity drug NB32</li>
<li>
		Tandem Diabetes Care Inc (NASDAQ: <a class="ticker" href="/stock/tndm#NASDAQ">TNDM</a>), designer of insulin pump technology</li>
<li>
		Kerry Group (OTC: <a class="ticker" href="/stock/kryay#OTC">KRYAY</a>), a top producer of food ingredients and flavors</li>
<li>
		Novo Nordisk A/S (NYSE: <a class="ticker" href="/stock/nvo#NYSE">NVO</a>), a top developer of insulin and diabetes care technology</li>
<li>
		WhiteWave Foods Co (NYSE: <a class="ticker" href="/stock/wwav#NYSE">WWAV</a>), producer of organic and plant-based dairy products</li>
<li>
		Dicks Sporting Goods Inc (NYSE: <a class="ticker" href="/stock/dks#NYSE">DKS</a>), a leading fitness equipment and apparel retailer</li>
<li>
		St. Jude Medical, Inc. (NYSE: <a class="ticker" href="/stock/stj#NYSE">STJ</a>), developer of cardiovascular medical devices</li>
</ul>

	According to the report, the economic impact of globesity is $2 trillion, similar to the financial impacts of smoking, armed violence, war and terrorism. Bank of America believes that smart investors can be well-positioned to benefit from the new world war against obesity.

Comments

Kerry Group

Kerry Group (KRYAY) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga